Block Listing Interim Review
CVS Group plc has provided an interim review of its block listing arrangements for the period from July 12, 2025, to January 12, 2026. During this period, 599 ordinary shares were issued under the CVS Group SAYE Plan, reducing the unallotted balance to 337,366 shares, while the CVS Long Term Incentive Plan had no shares issued, maintaining its unallotted balance at 68,393 shares. The company originally listed 350,000 ordinary shares for the SAYE plan on December 30, 2021, and 120,000 ordinary shares for the LTIP on May 15, 2023.
Select text to share a quote on X · sign in to keep highlights & notes in your CVSG notes
CVS, the UK's listed veterinary group and a leading provider of veterinary services, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements. References to securities are to the Company's ordinary shares of 0.2 pence each ("Ordinary Shares").
| Name of the company: | CVS Group plc | |||
| Name of relevant scheme: | 1. CVS Group SAYE Plan; and 2. CVS Long Term Incentive Plan | |||
| Period of return: | From: | 12 July 2025 | To: | 12 January 2026 |
| Balance of unallotted securities under scheme(s) from previous return: | 1. 337,965 2. 68,393 | |||
| Less: Number of securities issued / allotted under scheme(s) during period: | 1. 599 2. Nil | |||
| Equals: Balance under scheme(s) not yet issued / allotted at end of period: | 1. 337,366 2. 68,393 | |||
| Number and class of securities originally listed and the date of admission: | 1. 350,000 Ordinary Shares admitted on 30 December 2021 2. 120,000 Ordinary Shares admitted on 15 May 2023 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.